| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.028 | 0.6 |